Predicting responsiveness to GLP-1 pathway drugs using real-world data
Medications targeting the glucagon-like peptide-1 (GLP-1) pathway are an important therapeutic class currently used for the treatment of Type 2 diabetes (T2D). However, there is not enough known about which su...